- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases.
- Journal Rank: JCR - Q2 (Immunology) / CiteScore - Q2 (Pharmacology (medical))
- Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 17.4 days after submission; acceptance to publication is undertaken in 2.7 days (median values for papers published in this journal in the first half of 2022).
- Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Meet Us at the 15th Annual Meeting of Chinese Society for Immunology, 27–30 December 2022, Chongqing, China
MDPI's Newly Launched Journals in September 2022
Peer Review Week 2022 – Research Integrity: Creating and Supporting Trust in Research
Deadline: 20 December 2022
Deadline: 28 February 2023
Deadline: 31 March 2023
Deadline: 30 April 2023
Deadline: 7 December 2022
Deadline: 31 December 2022
Deadline: 14 January 2023
Deadline: 28 January 2023